120 related articles for article (PubMed ID: 26646045)
1. Personalized medicine with Omega-3 fatty acids for depression in children and pregnant women and depression associated with inflammation.
Su KP
J Clin Psychiatry; 2015 Nov; 76(11):e1476-7. PubMed ID: 26646045
[No Abstract] [Full Text] [Related]
2. Tolerability of omega-3 fatty acid supplements in perinatal women.
Freeman MP; Sinha P
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):203-8. PubMed ID: 17981449
[TBL] [Abstract][Full Text] [Related]
3. The Promise and Limitations of Anti-Inflammatory Agents for the Treatment of Major Depressive Disorder.
Raison CL
Curr Top Behav Neurosci; 2017; 31():287-302. PubMed ID: 27278642
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine for perinatal depression.
Freeman MP
J Affect Disord; 2009 Jan; 112(1-3):1-10. PubMed ID: 18692251
[TBL] [Abstract][Full Text] [Related]
5. Role of omega-3 Fatty acids for prevention or treatment of perinatal depression.
Borja-Hart NL; Marino J
Pharmacotherapy; 2010 Feb; 30(2):210-6. PubMed ID: 20099994
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
Nemets H; Nemets B; Apter A; Bracha Z; Belmaker RH
Am J Psychiatry; 2006 Jun; 163(6):1098-100. PubMed ID: 16741212
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids in major depressive disorder.
Freeman MP
J Clin Psychiatry; 2009; 70 Suppl 5():7-11. PubMed ID: 19909687
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.
Rees AM; Austin MP; Parker GB
Aust N Z J Psychiatry; 2008 Mar; 42(3):199-205. PubMed ID: 18247194
[TBL] [Abstract][Full Text] [Related]
9. INSUFFICIENT EVIDENCE FOR THE USE OF OMEGA 3 SUPPLEMENTS IN TREATING DEPRESSION.
Neurosciences (Riyadh); 2016 Jan; 21(1):84-5. PubMed ID: 27224974
[No Abstract] [Full Text] [Related]
10. Role of omega-3 fatty acids as a treatment for depression in the perinatal period.
Rees AM; Austin MP; Parker G
Aust N Z J Psychiatry; 2005 Apr; 39(4):274-80. PubMed ID: 15777365
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids and depression: from cellular mechanisms to clinical care.
Freeman MP; Rapaport MH
J Clin Psychiatry; 2011 Feb; 72(2):258-9. PubMed ID: 21382308
[No Abstract] [Full Text] [Related]
12. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression.
Logan AC
Altern Med Rev; 2003 Nov; 8(4):410-25. PubMed ID: 14653768
[TBL] [Abstract][Full Text] [Related]
13. How best to treat perinatal depression.
Nugent J
Nurs N Z; 2008 Jul; 14(7):14-5, 5. PubMed ID: 18751671
[No Abstract] [Full Text] [Related]
14. Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient.
Su KP; Shen WW; Huang SY
Eur Neuropsychopharmacol; 2001 Aug; 11(4):295-9. PubMed ID: 11532384
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Fatty acids and gestational length in a high-risk psychiatric population due to psychiatric morbidity and medication exposure during pregnancy.
Freeman MP; Cohen LS; McInerney K
J Clin Psychopharmacol; 2014 Oct; 34(5):627-32. PubMed ID: 25006815
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids for major depressive disorder.
Su KP; Wang SM; Pae CU
Expert Opin Investig Drugs; 2013 Dec; 22(12):1519-34. PubMed ID: 24083675
[TBL] [Abstract][Full Text] [Related]
17. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
18. Is low dietary intake of omega-3 fatty acids associated with depression?
Hakkarainen R; Partonen T; Haukka J; Virtamo J; Albanes D; Lönnqvist J
Am J Psychiatry; 2004 Mar; 161(3):567-9. PubMed ID: 14992986
[TBL] [Abstract][Full Text] [Related]
19. Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression.
Lin PY; Mischoulon D; Freeman MP; Matsuoka Y; Hibbeln J; Belmaker RH; Su KP
Mol Psychiatry; 2012 Dec; 17(12):1161-3; author reply 1163-7. PubMed ID: 22824812
[No Abstract] [Full Text] [Related]
20. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis.
Martins JG; Bentsen H; Puri BK
Mol Psychiatry; 2012 Dec; 17(12):1144-9; discussion 1163-7. PubMed ID: 22488258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
